Head and Neck Cancers - 27/07/26
, Sayak Choudhury, MBBS, MD, Manikandan MV, MBBS, MD, Suchismita Ghosh, MBBS, MD, Indraja Dev, MBBS, MDRésumé |
Imaging is the center-point in the management of head and neck squamous cell carcinomas (HNSCC), as it helps define the extent of the primary tumor, assess regional nodal involvement, detect distant metastases, guide treatment planning, and aid in prognostication and post-treatment surveillance. With advances in molecular imaging, the role of functional imaging techniques has expanded considerably, in particular 18F-fluorodeoxyglucose positron emission computed tomography-computed tomography (18F-FDG PET/CT) has demonstrated added value over conventional imaging and clinical assessment, leading to changes in staging. This article discusses the utility of FDG PET/CT in evaluation of HNSCC.
Le texte complet de cet article est disponible en PDF.Keywords : FDG PET/CT, Head and neck, Squamous cell cancer, Staging, Response assessment, Unknown primary, Second primary
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?